News | News By Subject | News by Disease News By Date | Search News

Atherosclerosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting     3/19/2012
Arena Pharmaceuticals, Inc. (ARNA) Announces Merck KGaA (MKGAF.PK) Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis     12/28/2009
GlaxoSmithKline (GSK) (JOBS) Starts New Trial on Clogged Arteries Drug     12/9/2009
U.S. OKs Wider Use of AstraZeneca PLC (AZN) Cholesterol Drug     11/9/2007
Karo Bio AB Development of Clinical Candidate LXR-623 Discontinued     9/20/2007
KineMed, Inc. and Merck & Co., Inc. (MRK) Enter Collaboration in Atherosclerosis     8/7/2007
EPIX Pharmaceuticals, Inc. (EPIX) Soars; No Immediate FDA Approval for Imaging Agent but Additional Clinical Trials No Longer Required     6/19/2007
Merck & Co., Inc. (MRK) Ends Development Of Arena Pharmaceuticals, Inc. (ARNA)'s Drug But Will Continue Collaboration     9/26/2006
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Announces MLN1202 Fully Met Primary Endpoint In Phase II Clinical Study Of Patients At High Risk For Atherosclerosis     5/31/2006
AtheroGenics (AGIX) Gets $50 Million Payment From AstraZeneca (AZN)     1/30/2006
AtheroGenics (AGIX) And AstraZeneca (AZN) Announce Late Stage License And Commercialization Agreement For Novel Atherosclerosis Drug AGI-1067; Deal Worth $1 Billion     12/22/2005
Lipid Sciences, Inc. (LIPD) Considering Possible Sale Of Company     8/10/2005

News from Around the Web
Childhood Vitamin D Levels Linked To Adult Atherosclerosis, University of Turku Study     2/12/2015
On The Link Between Periodontitis And Atherosclerosis, Boston University And University of Washington Study     7/11/2014
There's No Such Thing As Healthy Obesity, Kangbuk Samsung Hospital Study     5/2/2014
New Link Between High-Fat "Western" Diet and Atherosclerosis Identified, Columbia University Medical Center Study     10/10/2012
Macrophage Accumulation of Triglycerides Yields Insights Into Atherosclerosis, Veterans Affairs Medical Center Study     10/2/2012
Atorvastatin Failed to Slow Atherosclerosis in Pediatric Lupus, Duke University Study     1/6/2012
Gene Therapy Delivered Once to Blood Vessel Wall Protects Against Atherosclerosis in Rabbit Studies, University of Washington Reveals     7/20/2011
Drug Combo May Be Best for Plaque Regression, University of Calgary Study     5/2/2011
New Cell Therapy a Promising Atherosclerosis Treatment, Karolinska Institute Study Finds     3/2/2011
Social Stress Leads to Atherosclerosis, University of Gothenburg Study     12/7/2010
Light Shed on Triglyceride Metabolism, University of California, Los Angeles (UCLA) Study     8/9/2010
New Atherosclerosis Vaccine Gives Promising Results, Karolinska Institute Study     5/6/2010
Can Charcoal Fight Heart Disease In Kidney Patients?     11/2/2009
Inhibiting Cholesterol-associated Protein Reduces High-risk Blockages In Arteries, University of Pennsylvania School of Medicine Study     9/29/2008
Aspirin And Atherosclerosis: Mechanism Uncovered, Journal of Lipid Research     9/26/2008

Press Releases
The Medicines Company (MDCO) Reports First-Quarter 2016 Business And Financial Results     5/9/2016
Eli Lilly (LLY) Reports Third-Quarter 2015 Results, Revises 2015 Financial Guidance     10/22/2015
Resverlogix (RVX.TO) Presents New Data At The European Society of Cardiology Congress 2015 On RVX-208 'Apabetalone' A Selective BET Inhibitor     8/31/2015
Cerenis Therapeutics, Inc. Announces The Results Of The LOCATION Study     7/15/2015
Radiological Society of North America (RSNA) Release: Asymptomatic Atherosclerosis Linked To Cognitive Impairment     11/25/2014
Synageva BioPharma (GEVA) Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa     10/22/2014
LipoScience, Inc. Release: Study Published In Atherosclerosis Provides First Large-Scale, Real-World Evidence Of Link Between Low LDL Particle Levels And Reduced Risk Of Cardiovascular Disease     6/24/2014
Synageva BioPharma (GEVA) Highlights Data Presentations And Satellite Symposium At The European Atherosclerosis Society Congress     6/3/2014
AtheroNova Inc. (AHRO.OB) Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, A Potential Treatment For Atherosclerosis     2/27/2014
AtheroNova Inc. (AHRO.OB) Completes Enrollment In Phase 1 Clinical Trial Of AHRO-001, A Potential Treatment For Atherosclerosis     12/5/2013
Capstone Therapeutics (CAPS) Announces A Lipimetix Development, LLC Presentation At The American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit Of AEM-28 On Established Atherosclerotic Lesions     11/19/2013
VBL Therapeutics Discloses Data About VB-201 Novel Mechanism and Pre-Clinical Efficacy in Atherosclerosis     7/8/2013
Athera Biotechnologies and Boehringer Ingelheim Corporation Enter Into an Option Agreement on a Novel Therapy for Atherosclerosis     6/19/2013
vascuVis Awarded NSF SBIR Phase I Funding to Establish Vascucap Feasibility in Marketplace for Detection of Vulnerable Atherosclerotic Plaques     12/7/2012
AlphaCore Pharma Reports Positive Phase 1 Results for ACP-501 (rhLCAT) in Patients With Stable Atherosclerosis     10/9/2012